BIIB34:BVMF
Biogen Inc BDR
R$188.28
0.00%
(0.00) 1D
Sep 21, 4:31:47 PM GMT-3 · BRL
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BIIB34...
Mkt. cap
33.24B
Avg. vol.
6.00
Volume
0.00
52-wk high
R$191.00
52-wk low
R$121.32
Shares outstanding
147.75M
No. of employees
8K
Mkt. cap
33.24B
Avg. vol.
6.00
Volume
0.00
52-wk high
R$191.00
52-wk low
R$121.32
Shares outstanding
147.75M
No. of employees
8K
News stories
From web sources and news partners
Investing.com
·
2 hours ago
Biogen stock hits 52-week high at 225.88 USD
AD HOC NEWS
·
4 hours ago
Biogen stock slips after a lower close and analyst notes
Yahoo Finance
·
1 day ago
4 Alzheimer's Drug Stocks to Watch on World Alzheimer's Day
Profile
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the treatment of neurological diseases. The company's primary products are dimethyl fumarate, diroximel fumarate, interferon beta-1a, peginterferon beta-1a, and natalizumab, all for the treatment of multiple sclerosis; nusinersen for the treatment of spinal muscular atrophy; omaveloxolone for the treatment of Friedreich's ataxia; tofersen for the treatment of ALS; and dimethyl fumarate for the treatment of severe plaque psoriasis. The company also produces 5 biosimilars and has collaborations with Genentech for several drugs.
The company is ranked 424th on the Fortune 500 and 845th on the Forbes Global 2000. Wikipedia
About Biogen Inc BDR
CEOChris Viehbacher
Employees7.5K
Founded1978
HeadquartersCambridge, Massachusetts, United States
SectorBiotechnology
Websitebiogen.com